Mizuho Lowers Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $20.00
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its target price reduced by Mizuho from $30.00 to $20.00 in a report issued on Wednesday morning,Benzinga reports. They currently have a neutral rating on the stock. APLS has been the subject of a number of other reports. Royal Bank of Canada lowered their price objective on shares […]
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its target price reduced by Mizuho from $30.00 to $20.00 in a report issued on Wednesday morning,Benzinga reports. They currently have a neutral rating on the stock. APLS has been the subject of a number of other reports. Royal Bank of Canada lowered their price objective on shares […]
